Σεπ302016

Evaluation of neutrophil/leukocyte ratio and organ failure score as predictors of reversibility and survival following an acute-on-chronic liver failure event

Εργασίες Ελλήνων ιατρών30 Σεπτεμβρίου 2016

Evaluation of neutrophil/leukocyte ratio and organ failure score as predictors of reversibility and survival following an acute-on-chronic liver failure event. Agiasotelli D, Alexopoulou A, Vasilieva L, Kalpakou G, Papadaki S, Dourakis SP. Hepatol Res. 2016 May;46(6):514-20. doi: 10.1111/hepr.12582. Epub 2015 Oct 6. Για να δείτε το άρθρο πιέστε εδώ

Λεπτομέρειες

Σεπ302016

Discontinuation of oral antivirals in chronic hepatitis B: A systematic review

Εργασίες Ελλήνων ιατρών30 Σεπτεμβρίου 2016

Discontinuation of oral antivirals in chronic hepatitis B: A systematic review. Papatheodoridis G, Vlachogiannakos I, Cholongitas E, Wursthorn K, Thomadakis C, Touloumi G, Petersen J. Hepatology. 2016 May;63(5):1481-92. doi: 10.1002/hep.28438. Epub 2016 Mar 4. Για να δείτε το άρθρο πιέστε εδώ

Λεπτομέρειες

Σεπ302016

Extensively drug-resistant bacteria are an independent predictive factor of mortality in 130 patients with spontaneous bacterial peritonitis or spontaneous bacteremia

Εργασίες Ελλήνων ιατρών30 Σεπτεμβρίου 2016

Extensively drug-resistant bacteria are an independent predictive factor of mortality in 130 patients with spontaneous bacterial peritonitis or spontaneous bacteremia. Alexopoulou A, Vasilieva L, Agiasotelli D, Siranidi K, Pouriki S, Tsiriga A, Toutouza M, Dourakis SP. World J Gastroenterol. 2016 Apr 21;22(15):4049-56. doi: 10.3748/wjg.v22.i15.4049. Για να δείτε το άρθρο πιέστε εδώ

Λεπτομέρειες

Σεπ302016

TGF-β signaling is activated in patients with chronic HBV infection and repressed by SMAD7 overexpression after successful antiviral treatment

Εργασίες Ελλήνων ιατρών30 Σεπτεμβρίου 2016

TGF-β signaling is activated in patients with chronic HBV infection and repressed by SMAD7 overexpression after successful antiviral treatment. Argentou N, Germanidis G, Hytiroglou P, Apostolou E, Vassiliadis T, Patsiaoura K, Sideras P, Germenis AE, Speletas M. Inflamm Res. 2016 May;65(5):355-65. doi: 10.1007/s00011-016-0921-6. Epub 2016 Feb 9. Για να δείτε το άρθρο πιέστε εδώ

Λεπτομέρειες

Μαρ282016

PAGE-B predicts the risk of developing hepatocellular carcinoma in Caucasians with chronic hepatitis B on 5-year antiviral therapy

Εργασίες Ελλήνων ιατρών28 Μαρτίου 2016

Background & Aims: Risk scores for hepatocellular carcinoma (HCC) developed in Asians offer poor-moderate predictability in Caucasian patients with chronic hepatitis B (CHB). This nine center cohort study aimed to develop and validate an accurate HCC risk score in Caucasian CHB patients treated with the current oral antivirals, entecavir/tenofovir. Για να δείτε τη συνέχεια πιέστε…

Λεπτομέρειες

Μαρ282016

A real-world study focused on the long-term efficacy of mycophenolate mofetil as first-line treatment of autoimmune hepatitis

Εργασίες Ελλήνων ιατρών28 Μαρτίου 2016

Background Front-line therapy with mycophenolate mofetil (MMF) in autoimmune hepatitis (AIH) has shown high on-treatment remission rates. Για να δείτε τη συνέχεια πιέστε εδώ

Λεπτομέρειες

Φεβ32014

Autoimmune hepatitis – current management and challenges

Εργασίες Ελλήνων ιατρών3 Φεβρουαρίου 2014

Autoimmune hepatitis remains a major diagnostic and therapeutic challenge. The clinician, the hepato-pathologist and the laboratory personnel need to become more familiar with different expressions of the disease, interpretation of liver histology and autoimmune serology.

Λεπτομέρειες